About Parabilis Medicines Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of
£44,801 to £47,071 per annum This is fixed-term position until 17 June 2035 due to time limited funding from an external grant. Overall purpose: To work within the group of Leo James at the MRC Laboratory